144701-48-4

  • Product Name:Telmisartan
  • Molecular Formula:C33H30N4O2
  • Purity:99%
  • Molecular Weight:514.627
Inquiry

Product Details;

CasNo: 144701-48-4

Molecular Formula: C33H30N4O2

Appearance: White or off white crystalline powder

We supply high quality Telmisartan (CAS 144701-48-4), in stock, factory directly supply to clients, lower prices, more competitiveness.

What is the Telmisartan ?

Telmisartan is an angiotensin II receptor blocker (ARB) medication used to treat conditions such as high blood pressure (hypertension), heart failure, and diabetic kidney disease. It functions by blocking the action of angiotensin II, a substance that causes blood vessels to constrict, thereby relaxing blood vessels, lowering blood pressure, and improving blood flow to the heart.

What is the CAS number for Telmisartan ?

The CAS number of Telmisartan is 144701-48-4.

What is Telmisartan (144701-48-4) used for?

Telmisartan is primarily prescribed to manage high blood pressure, a condition that increases the workload on the heart and arteries, potentially leading to cardiovascular complications if left untreated. By blocking angiotensin II receptors, telmisartan helps to lower blood pressure and reduce the risk of associated health problems. In individuals with heart failure, telmisartan may be used as part of the treatment regimen to improve heart function and reduce symptoms such as shortness of breath and fatigue. By promoting vasodilation and increasing blood flow to the heart, telmisartan can help alleviate the strain on the heart muscle. Clinical trials have demonstrated that telmisartan is as effective as other major classes of antihypertensive agents in lowering blood pressure. Additionally, compared to certain other antihypertensive medications like lisinopril, telmisartan is associated with a lower incidence of side effects such as dry, persistent cough, making it a preferred option for some patients.

Articles related to Telmisartan:

Article

Source

Effect of Telmisartan on Renal Outcomes

No important difference was found in the composite renal outcome with telmisartan (58 patients [1.96%]) versus placebo (46 patients [1.55%]) (hazard ratio, 1.29 [95% CI, 0.87 to 1.89]; P = 0.20). Among the telmisartan and placebo groups, 7 and 10 patients had dialysis and 56 and 36 patients had doubling of serum creatinine, respectively (hazard ratio, 1.59 [CI, 1.04 to 2.41]; P = 0.031).

, Annals of Internal Medicine, 7 July 2009

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

In patients who have vascular disease or high-risk diabetes without heart failure, angiotensin-converting–enzyme (ACE) inhibitors reduce mortality and morbidity from cardiovascular causes, but the role of angiotensin-receptor blockers (ARBs) in such patients is unknown. We compared the ACE inhibitor ramipril, the ARB telmisartan, and the combination of the two drugs in patients with vascular disease or high-risk diabetes.

, N Engl J Med 2008; 358:1547-1559

Sale! Factory Supply High Purity Telmisartan 144701-48-4 Competitive Price

Hebei Nengqian Chemical Import and Export Co., LTD is a quality factory of Telmisartan . You can buy high purity, low price Telmisartan 144701-48-4 here. Contact us.

Relevant Products